Back to Article List

New specification for steviol glycoside under evaluation by FSANZ

Australia

Aug 30, 2021

FSANZ is evaluating approval of a new specification for the steviol glycoside, rebaudioside I, produced by enzymatic bioconversion of stevia leaf extract. Bioconversion enzymes are derived from a genetically modified yeast strain, Pichia pastoris.

For further information (in English), click on the Link

Related Articles
See All News
Subscribe to our newsletter

The best industry insight in your mailbox